Based on our knowledge, up to now, there has not been a report on the effect of zinc nanoparticles on obesity-induced cardiovascular disease concerning iron overload, blood pressure, insulin resistance, adipocyte hormones, and inflammatory markers. The gene discussed is INS; the disease is cardiovascular disorder.